SCHEMBL6537828

SCHEMBL6537828

CNCCNc1ccnc2c(NC(=O)c3ccccc3[N+](=O)[O-])cccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
GAA P10253 1/20 0.46
HTT P42858 1/20 0.46
NCOA1 Q15788 1/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46
ABCG2 Q9UNQ0 1/20 0.46
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
MAPK1 P28482 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MAPT P10636 3/20 0.44
NSD2 O96028 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537644 0.84 CYP1A2 (0.51) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL6537479 0.83 ALDH1A1 (0.49) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL6538307 0.82 MEN1 (0.48) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6537662 0.81 MEN1 (0.61) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL6537677 0.77 SMN1; SMN2 (0.52) ALDH1A1CYP3A4SMN1; SMN2HTTMAPT
SCHEMBL11995707 0.76 MAPT (0.67) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL30733199 0.76 MAPT (0.67) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL6537586 0.75 KDM4E (0.53) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL6537671 0.74 SMN1; SMN2 (0.47) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL6537546 0.74 KMT2A (0.48) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed